Dental implants offer clear advantages over other treatment procedures used to replace missing teeth. Although price is a prime factor hindering penetration and expansion, there exists considerable untapped growth potential in the Western European dental implants market.
Advanced technology and innovative techniques are some of the ways in which participants distinguish themselves. Research and innovation, along with intensive marketing strategies and increased awareness among patients and dentists, will promote market prospects.
New analysis from Frost & Sullivan (medicaldevices.frost.com), Western European Dental Implants Market, finds that the market earned $ 928.9 million in 2010 and estimates this to reach $ 1497.1 million in 2017. Europe is the major revenue generator for the dental implants market.
“Marketing strategies adopted by dental implant manufacturers have changed the outlook of patients and dental practitioners, encouraging the use of such procedures”, notes Frost & Sullivan Research Associate Brahadeesh Chandrasekaran. “Over the last few years, there has been a significant increase in direct-to-consumer marketing, resulting in increased awareness of dental implants.”
Heightened interest and awareness among patients about cosmetic dentistry is also supporting market expansion. At the same time, technological advances and innovation are simplifying dental implant procedures and providing enhanced solutions.
“Most dental implant manufacturers have started focusing on simpler protocols, tools and procedures,” explains Brahadeesh. “The recent advancements in technology and innovation like CAD/CAM and mini implants have resulted in easier procedures.”
Advances in guided surgery and imaging have led to more single-stage or one-step implant procedures. This denotes a clear advantage for patients, as multi-step procedures require more time before the final tooth restoration.
Compared to alternative treatment procedures, dental implants offer several long-term benefits. These include improved aesthetic appearance and better hygiene. The increase in technology has already enhanced the quality of both implants and surgery.
A major challenge is the presence of large companies with branded products, which limits the influence of emerging and new entrants. Clinicians prefer to work with large companies that have high-quality R&D platforms, can organise educational programmes for dental practitioners and can assist if there is any product-related issue.
Moreover, long-term knowledge and experience in continuously monitoring the performance of the implants in patients is important for product sales. Another crucial factor is the huge investments required for product marketing and sales.
All these factors threaten the prospects of entrants. It is crucial, therefore, for entrants to focus on R&D, along with good infrastructure, to gain recognition from dentists.
“Although the dental implant market is considered to be fragmented, it is very difficult for new participants to enter, especially in western Europe,” remarks Brahadeesh. “Large multinational companies can acquire small market participants, while a smaller company with state-of-the-art products can partner with other companies, thereby expanding their services and product portfolio.”
Currently, only 2 to 3 per cent of edentulous people are being treated with implant procedures, signifying huge untapped potential. Against a backdrop of improved standards of living and the rise of regenerative medicine, direct marketing will play a crucial role in determining the future of the market over the next decade.
“In a market driven by technology and innovation, dental implant manufacturers need to develop a strong research base to acquire high performing, reliable and cost-effective materials and products,” concludes Brahadeesh. “They also need to ensure that their products reach end-users and consumers through effective and ethical means of marketing.”
If you are interested in more information on this study, please send an email with your contact details to Janique Morvan, Corporate Communications, at janique.morvan[.]frost.com.
Western European Dental Implants Market is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: Eastern European Decontamination Equipments Market, European Orthopaedic Devices Market Outlook, Western European Markets for Peripheral Vascular Products, European Markets for Peripheral Vascular Stents and AAA Stent-Grafts, among others. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.
Western European Dental Implants Market / M6B8